GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Thetimefarm@lemm.eeEnglish
    42·
    1 year ago

    As long as it’s for research and stays HIPPA compliant I don’t really have an issue with it. This would be a good use for AI but that’s also kinda horrifying to think about. Having millions of unique human DNA samples to train your AI on would be worth something I presume.